Join the Business Power Network at McAllen Chamber

Breaking News
913

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Scheduled for Tuesday, February 11 

Come network with other Chamber members at this monthly event. Reserve your spot with Anabel at 682-2871.

Attention Health Care industry members!! Don’t miss out on the Health Body Mind Expo scheduled for Sunday, February 16 from 8:30 am – 1:30 pm at the McAllen Convention Center. Over 6,000 people are expected to attend so don’t miss this great opportunity to promote your products or services to the community.

- Advertisement -

Call Yajaira to reserve your booth at 682-2871! Entrance to the event is absolutely free to the public.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Second Spike in Flu Cases Recorded
Next article
Retina Surgeon Speaks About Screening for Eye Disease

More Articles

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -